Publications
In our most recent case studies, market research reports, conference talks, and other publications, we share and visualize our market insights.
Get in Touch
Clients and Partners
In our most recent case studies, market research reports, conference talks, and other publications, we share and visualize our market insights.
Clients and Partners
Digital Oxygen GmbH | Imprint | Privacy Policy | Consulting Swag
DiPA Canvas 2023
With the DiPA Canvas, Digital Oxygen provides a straight-forward tool for the self-assessment of essential questions for any DiPA manufacturer.
DiGA Canvas 2023
The DiGA Canvas is a comprehensive tool to assess the crucial questions, challenges, and requirements for your DiGA.
Pharma and the 4D – Opportunity or Threat?
In this article, Torsten Christann comments on the importance, opportunities, and downsides of data for the pharma industry’s future business models.
Advanced Diabetes Technology Landscape 2022
The Advanced Diabetes Technology Landscape 2022 gives a structured overview of the companies shaping the future of Diabetes Care.
DiGA Partnerships: Start-ups Meet Corporates
There is a trend of DiGA start-ups looking for corporate partners and vice versa. But why?
Digital Health Due Diligence (Whitepaper)
Our case study and framework showcases the relevant dimensions and questions to be asked when considering a DiGA acquisition.
Self-Measurement as Opportunity for Real-World-Evidence in Market Access
Sensors, wearables, apps: Torsten Christann comments on the opportunities of self-measurement for the generation of Real-World-Evidence in Market Access processes.
Apps On Prescription and Big Pharma: A Beneficial Combination?
In this article, Torsten Christann addresses the question whether pharma corporations should add DiGA to their portfolio.
Enduring DiGA Success: Reaching Patients After Market Access
At WIG2 Digital Health Conference, Healthcare Expert Alexander Voigt talked about what matters after the regulatory market access: Reaching patients.
Connected Diabetes Care in Hospitals (Case Study)
This study examines the pain points and inefficiencies of diabetes care in German hospitals – and how there is a case for Glucometry MedTechs to disrupt the industry.